Clinical Study on Laparoscopic Resection of Splenic Artery Aneurysm With Preservation of Spleen
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNorthern Jiangsu People's Hospital
About this trial
In this study, researchers examined the changes in related indicators such as immune function, splenic vein,proper hepatic artery, and portal venous hemodynamics following laparoscopic resection of a splenic artery aneurysm. We determined the changes in these patient-related indicators after surgical treatment and whether these changes could improve patient outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Asymptomatic splenic artery aneurysms with a diameter>2 cm,ruptured splenic artery aneurysms,and splenic artery aneurysms with a diameter increase>0.5 cm/year.
Disqualifiers
Patients with malignancies Hepatic cirrhosis with portal hypertension peptic ulcer disease Recent peptic ulcer disease History of Hemorrhagic stroke Pregnancy hematological diseases Uncontrolled Hypertension Human immunodeficiency virus (HIV) infection
Trial design
Design model
Single group
Treatments tested in this trial
laparoscopic resection of splenic artery aneurysm with preservation of spleen
Procedure/SurgeryThe laparoscopic resection of splenic artery aneurysm with preservation of spleen is performed by the same surgical team.
Treatment groups
10 Participants
are divided into 1 treatment groupGroup A: The laparoscopic resection of splenic artery aneurysm is performed by the same surgical team.Experimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
The immune function at 7 days after surgery
The level of the immune function(Complement C3; Complement C4; IgG; IgA; IgM;CD19;CD20;CD16;CD56;CD3;CD4) at 7 days after surgery.
Time frame
7 days2
The immune function at 1 month after surgery
The level of the immune function(Complement C3; Complement C4; IgG; IgA; IgM;CD19;CD20;CD16;CD56;CD3;CD4) at 1 month after surgery.
Time frame
1 month3
The immune function at 3 months after surgery
The level of the immune function(Complement C3; Complement C4; IgG; IgA; IgM;CD19;CD20;CD16;CD56;CD3;CD4) at 3 months after surgery.
Time frame
3 months4
The immune function at 6 months after surgery
The level of the immune function(Complement C3; Complement C4; IgG; IgA; IgM;CD19;CD20;CD16;CD56;CD3;CD4) at 6 months after surgery.
Time frame
6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov